On the evaluation of the safety aspects of nanomaterials in medical devices - a regulatory perspective

被引:4
|
作者
Wu, Eva [1 ]
Chan, Christopher [1 ]
Li, Albert T. W. [1 ]
机构
[1] Ind Technol Res Inst, Off Med Device Evaluat, Ctr Measurement Stand, Zhudong, Taiwan
来源
ADMET AND DMPK | 2013年 / 1卷 / 04期
关键词
nanotechnology; nanomaterial; regulatory; medical device; risk management; usability;
D O I
10.5599/admet.1.4.19
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nanotechnology is widely used in many aspects of the design and manufacture of medical devices. To date, many of these new medical devices, referred to as nano medical devices, have been submitted to health authorities for premarket regulatory review. There are ongoing discussions between medical device manufacturers and regulatory authorities regarding the standards and methods required for the evaluation process. Taking into consideration aspects including nano-toxicology and biocompatibility, the clinical effects of nanotechnology and risk management, there are issues yet to be resolved. In this article, we will discuss nano medical device safety from the regulatory control point of view.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 50 条
  • [1] Genotoxicity evaluation of medical devices: A regulatory perspective
    Kumaravel, Tirukalikundram S.
    Sathya, Tiruvathipuram N.
    Balaje, Ramalingam
    Pradeepa, Pitchaipillai
    Yogaraj, Desikan
    Murali, Malliga R.
    Navaneethakrishnan, K. R.
    Murugan, Sivasubramanian
    Jha, Awadhesh N.
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2022, 789
  • [2] Medical devices, regulatory and safety reminders
    Guerriaud, Mathieu
    [J]. ACTUALITES PHARMACEUTIQUES, 2022, 61 (616): : 42 - 45
  • [3] REGULATORY ASPECTS OF CONTRACEPTIVE DEVICES - A CANADIAN PERSPECTIVE
    SMITH, M
    [J]. CONTRACEPTIVE DELIVERY SYSTEMS, 1983, 4 (04) : 25 - 25
  • [4] Statistical issues in medical devices: A regulatory perspective
    Campbell, G
    [J]. AMERICAN STATISTICAL ASSOCIATION - 1996 PROCEEDINGS OF THE BIOPHARMACEUTICAL SECTION, 1996, : 224 - 229
  • [5] An overview of the state of the regulatory and preclinical requirements for nanomaterials including medical devices
    Rehman, Naheed
    Moore, Simon
    [J]. INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT, 2021, 17 (06) : 1098 - 1104
  • [6] Nanostructured Medical Devices: Regulatory Perspective and Current Applications
    D'Avenio, Giuseppe
    Daniele, Carla
    Grigioni, Mauro
    [J]. MATERIALS, 2024, 17 (08)
  • [7] INTERSTITIAL LASER DEVICES IN MEDICAL APPLICATIONS: REGULATORY PERSPECTIVE
    Chen, Kejing
    Chen, Long
    Felten, Richard
    Vaezy, Shahram
    Ohara, Michael
    Ogden, Neil
    [J]. LASERS IN SURGERY AND MEDICINE, 2013, 45 : 63 - 63
  • [8] Regulatory Aspects of Nanomaterials in the EU
    Rauscher, Hubert
    Rasmussen, Kirsten
    Sokull-Kluttgen, Birgit
    [J]. CHEMIE INGENIEUR TECHNIK, 2017, 89 (03) : 224 - 231
  • [9] Medical Devices Regulatory Aspects: A Special Focus on Polymeric Material Based Devices
    Sridhar, Radhakrishnan
    Pliszka, Damian
    Luo, He-Kuan
    Lim, Keith Hsiu Chin
    Ramakrishna, Seeram
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (42) : 6246 - 6259
  • [10] A regulatory perspective on recombinant collagen-based medical devices
    Liu, Wenbo
    Lin, Hai
    Zhao, Peng
    Xing, Lina
    Li, Jie
    Wang, Zehua
    Ju, Shan
    Shi, XinLi
    Liu, Yinghui
    Deng, Gang
    Gao, Guobiao
    Sun, Lei
    Zhang, Xindong
    [J]. BIOACTIVE MATERIALS, 2022, 12 : 198 - 202